This inventor holds 1 USPTO granted patent. Top assignee: Midatech Limited. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Jon Golding: Innovator in Cancer Therapy
Introduction
Jon Golding is a notable inventor based in Milton Heynes, GB. He has made significant contributions to the field of cancer therapy through his innovative work with nanoparticles. His research focuses on developing advanced methods for treating cancer, particularly skin cancer, in mammalian subjects.
Latest Patents
Jon Golding holds a patent for his invention titled "Nanoparticles and their use in cancer therapy." This patent describes a nanoparticle that comprises a core made of metal and a corona consisting of various ligands covalently linked to the core. The ligands include a first species with an ethylene glycol portion and an amine group, as well as a second species featuring a carbohydrate group. This invention aims to provide effective treatment methods for cancer, especially skin cancer, and includes methods of administering the nanoparticles either alone or in combination with radiotherapy. He has 1 patent to his name.
Career Highlights
Jon Golding is associated with Midatech Limited, where he continues to work on innovative solutions in the field of cancer treatment. His expertise and dedication to research have positioned him as a key figure in the development of nanoparticle technology for medical applications.
Collaborations
Throughout his career, Jon has collaborated with talented individuals such as Phillip Williams and Meike Roskamp. These partnerships have enhanced his research efforts and contributed to the advancement of cancer therapy technologies.
Conclusion
Jon Golding's work in the field of cancer therapy through nanoparticle innovation showcases his commitment to improving treatment options for patients. His contributions are paving the way for future advancements in medical technology.